tiprankstipranks
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
US Market
LXEO
Lexeo Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see LXEO full AI Analyst Report?

Lexeo Therapeutics, Inc. (LXEO) Financial Statements

291 Followers

Lexeo Therapeutics, Inc. Financial Overview

Lexeo Therapeutics, Inc.'s market cap is currently $421.93M. The company's EPS TTM is $-0.27; its P/E ratio is -63.66; Lexeo Therapeutics, Inc. is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 654.00K$ 1.66M
Gross Profit$ 0.00$ 0.00$ 0.00$ 654.00K$ 1.66M
Operating Income$ -109.26M$ -105.77M$ -68.51M$ -60.51M$ -50.64M
EBITDA$ -97.68M$ -96.19M$ -64.35M$ -58.04M$ -50.61M
Net Income$ -99.96M$ -98.33M$ -66.39M$ -59.28M$ -50.62M
Balance Sheet
Cash & Short-Term Investments$ 181.77M$ 121.52M$ 121.47M$ 77.33M$ 135.86M
Total Assets$ 268.69M$ 146.94M$ 139.81M$ 97.08M$ 136.86M
Total Debt$ 7.89M$ 9.92M$ 11.64M$ 13.48M$ 0.00
Net Debt$ -55.11M$ -25.09M$ -109.83M$ -63.85M$ -135.86M
Total Liabilities$ 22.02M$ 30.10M$ 26.27M$ 210.03M$ 192.46M
Stockholders' Equity$ 246.67M$ 116.84M$ 113.53M$ -112.95M$ -55.60M
Cash Flow
Free Cash Flow$ -98.96M$ -81.63M$ -59.66M$ -55.46M$ -44.37M
Operating Cash Flow$ -98.56M$ -81.15M$ -59.50M$ -54.56M$ -44.18M
Investing Cash Flow$ -90.25M$ -94.08M$ -165.00K$ -901.00K$ -188.00K
Financing Cash Flow$ 216.79M$ 88.78M$ 103.79M$ 189.00K$ 150.86M
Currency in USD

Lexeo Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Lexeo Therapeutics, Inc. Debt to Assets

Balance Sheet >

Lexeo Therapeutics, Inc. Cash Flow

Cash Flow >

Lexeo Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >